Searched for
FOREST LABORATORIES INC
Pharma sector: Look beyond the tariff reprieve for generics. 6 mid-cap pharma stocks with an upside potential of more than 23%With US President Trump, nothing can be ruled out. But, for now at least, Indian pharma companies can breathe a little easier. The 100% tar...- Mid-cap pharma space: Risk & opportunity are two sides of the same coin. 7 pharma stocks with upside potential of up to 41%Two things increase the probability of a sector becoming the next big sector in India. One: As a country, India should have some edge in th...
- Listen beyond the noise from Trump, think beyond Nifty’s volatility: 8 mid and 1 small cap pharma stock with upside potential of up to 46%With the Nifty moving up for just two days, have we forgotten what happened to stock prices in the past six months? This is where we all ma...
- Comeback and re-rating supported by numbers? 5 pharma stocks with upside potential of up to 21%Both at the real business condition and on the valuation cycle on the street. The Indian pharmaceutical sector has undergone significant ch...
- Glenmark Pharmaceuticals settles patent litigation over anti-depressant drugGlenmark Pharmaceuticals announced a patent litigation settlement with Forest Laboratories and Royalty Pharma Collection Trust over anti-de...
- Brent Saunders gets key job as Pfizer, Allergan combineSaunders, 45, an intrepid deal maker, has a history of eventually leading companies that he had helped combine.
- Aurobindo Pharma gets US FDA nod for Alzheimer's drug Memantine HydrochlorideAurobindo Pharma said it has received final approval from the US FDA to manufacture and market Memantine Hydrochloride used in treatment of...
- Glenmark receives USD 4 mn from Forest Lab as research feeThe company through its Swiss unit has received USD 4 million as research fee payment from Forest Laboratories Inc for the development of n...
- Glenmark gets research fee payment from Forest LaboratoriesThe company is expecting an additional payment to support the advancement of the programme, Glenmark Pharmaceuticals said.
- Glenmark gets USFDA nod for alcohol abstinence drugGlenmark Pharma said it has received US health regulator's approval to market generic version of Forest Laboratories' Campral Delayed Relea...
- Glenmark inks drug development pact with Forest LaboratoriesAs part of the agreement, Glenmark will receive up to $ 9 million (around Rs 50 crore) from US-based Forest Laboratories Inc.
- Glenmark Pharmaceuticals hits 52-week high on pact with Forest LaboratoriesGlenmark surged over 4% to hit its 52-week high of Rs 519.70 after the company said its subsidiary has signed an agreement with Forest Labs.
- Unichem gets tentative nod from USFDA for dementia tabletsDrug firm Unichem Laboratories today said it has received tentative approval from the US health regulator for its Memantine Hydrochloride t...
- Jubilant Life's four medicines get USFDA approvalJubilant Life Sciences said it has received approvals from the US health regulator for 4 products that target CNS and CVS therapeutic areas.
- Aurobindo Pharma gets USFDA approval for anti-depressantAurobindo Pharma said it has received final approval from the US health regulator to manufacture generic version of Lexapro.
- US MNCs lobby to alter tax rules they soughtUS MNCs have been seeking a tax break on overseas income for yrs, & the top Republican tax writer in Cong is proposing to give it to them.
- Sun's Caraco settles litigation with Forest Lab in USThe Rs 4,300-crore Sun Pharmaceuticals Ltd's US-subsidiary, Caraco Pharmaceuticals Laboratories Ltd, has gone for settlement of the legal p...
- Glenmark to enter Europe with Rs 100 crore buyLeading mid-sized pharma company Glenmark Pharmaceuticals would soon enter the European market by acquiring a front-end pharmaceutical comp...
- TCG LifeSc, Forest Lab in drug discovery pactTCG Lifesciences on Monday said it has entered into a pact with the US-based Forest Laboratories for drug discovery to treat inflammatory d...
- Glenmark to make Europe foray with Rs 100 cr buyLeading mid-sized pharma company Glenmark Pharmaceuticals will soon enter the European market by acquiring a front-end pharmaceutical compa...
Load More
